Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Letter to the editor
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Letter to the editor

Letter to the editor

Bibliographic Details
Main Authors: Francisco José Fernández - Fernández, Eugenia Ameneiros-Lago, Pascual Sesma
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2012-01-01
Series:Swiss Medical Weekly
Subjects:
Giant-cell arteritis
interleukin-6
tocilizumab
Online Access:https://www.smw.ch/index.php/smw/article/view/1410
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.smw.ch/index.php/smw/article/view/1410

Similar Items

  • EXPERIENCE WITH TOCILIZUMAB, AN INTERLEUKIN 6 INHIBITOR, USED FOR THE TREATMENT OF GIANT CELL ARTERITIS WITH SEVERE COMORBIDITY
    by: T. V. Beketova, et al.
    Published: (2018-05-01)
  • Improvement of Treg immune response after treatment with tocilizumab in giant cell arteritis
    by: Maxime Samson, et al.
    Published: (2021-01-01)
  • Pharmacotherapy of giant cell arteritis and polymyalgia rheumatica: Prospects for the use of monoclonal antibodies to interleukin 6
    by: Evgeny L. Nasonov, et al.
    Published: (2024-09-01)
  • Profile of tocilizumab and its potential in the treatment of giant cell arteritis
    by: Mollan SP, et al.
    Published: (2018-01-01)
  • INNOVATIVE TREATMENTS FOR TAKAYASU’S ARTERITIS: A FOCUS ON INTERLEUKIN-6 INHIBITORS. THE AUTHORS’ EXPERIENCE WITH TOCILIZUMAB AND A REVIEW OF LITERATURE
    by: T. V. Beketova, et al.
    Published: (2017-10-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs